Definitive Healthcare (NASDAQ:DH) Updates Q1 2025 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.020-0.020 for the period, compared to the consensus earnings per share estimate of 0.070. The company issued revenue guidance of $55.5 million-$57.0 million, compared to the consensus revenue estimate of $60.0 million. Definitive Healthcare also updated its FY 2025 guidance to 0.190-0.220 EPS.

Analysts Set New Price Targets

DH has been the topic of a number of analyst reports. Barclays reaffirmed an “underweight” rating and set a $4.00 price objective on shares of Definitive Healthcare in a research note on Monday, January 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Finally, Stephens began coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price on the stock. Two research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $5.72.

Definitive Healthcare Stock Down 3.5 %

Shares of NASDAQ DH opened at $4.92 on Friday. Definitive Healthcare has a 52-week low of $3.19 and a 52-week high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The company’s 50-day simple moving average is $4.63 and its 200-day simple moving average is $4.47. The firm has a market cap of $568.37 million, a price-to-earnings ratio of -1.59, a price-to-earnings-growth ratio of 4.06 and a beta of 1.45.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Equities analysts predict that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 14.84% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.